Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Wednesday, February 25, 2015

ViaCyte, Inc. (Formerly Known as Novocell, Inc.) To Present At 35th...

A Phase 1/2 trial called STEP ONE, or ViaCyte is a privately-held regenerative medicine company focused on developing a novel cell therapy for the treatment of diabetes. ViaCyte is conducting a Phase 1/2 clinical trial of the Company's VC-01 lead product candidate in patients with type 1 diabetes who have minimal to no insulin-producing beta cell function.

http://ift.tt/1FtKcZ3

No comments:

Post a Comment

Popular Stem Cell Roundup Posts